Frank Gleeson

Founder at SATELLOS BIOSCIENCE INC.

Net worth: 2 M $ as of 2026-05-30

70 year

6 connections

Health Technology

Commercial Services

Consumer Services

Profile

Frank Gleeson is the founder of Verio Therapeutics, Inc., founded in 2008.
Mr. Gleeson was the founder of Satellos Bioscience, Inc., founded in 2018, and held the title President & Chief Executive Officer.
Mr. Gleeson is the founder of Satellos Bioscience, Inc., founded in 2012, and holds the titles President, Chief Executive Officer & Director since 2018.
Mr. Gleeson is also the founder of Gleeson & Associates,Canadian Glycomics Network..
Mr. Gleeson was Chief Executive Officer at MDS Proteomics, Inc. from 1999 to 2003.
Mr. Gleeson was Chairman at Stem Cell Network.
Mr. Gleeson was Director at Privacy Analytics, Inc. Mr. Gleeson was Senior Vice President at Mercal Capital Corp.
Mr. Gleeson completed undergraduate and MBA degrees at York University.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
SATELLOS BIOSCIENCE INC 1.59%	2026-04-01	331,365 ( 1.59% )	2 M $	2026-05-30

Frank Gleeson active positions

Companies	Position	Start
SATELLOS BIOSCIENCE INC.	Founder	2012-06-30
Gleeson & Associates	Founder	-

All active positions of Frank Gleeson

Former positions of Frank Gleeson

Companies	Position	End
MDS Proteomics, Inc. MDS Proteomics, Inc. Miscellaneous Commercial ServicesCommercial Services Researches and analyzes proteins to determine their role in disease	Chief Executive Officer	2002-12-31
Canadian Glycomics Network Canadian Glycomics Network BiotechnologyHealth Technology Develops new carbohydrate-based drugs, vaccines and diagnostics	Founder	-
Verio Therapeutics, Inc. Verio Therapeutics, Inc. BiotechnologyHealth Technology Manufactures pharmaceutical products for activating endogenous stem cells	Founder	-
Stem Cell Network Stem Cell Network Miscellaneous Commercial ServicesCommercial Services Engages in research & development and offers funding for stem cell regenerative medicine and provides training services	Chairman	-
Satellos Bioscience, Inc. /Old/ Satellos Bioscience, Inc. /Old/ BiotechnologyHealth Technology Engages in research and development of stem cell regeneration	Chief Executive Officer	-

See the detail of Frank Gleeson's experience

Training of Frank Gleeson

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Frank Gleeson's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	10
MDS Proteomics, Inc. MDS Proteomics, Inc. Miscellaneous Commercial ServicesCommercial Services Researches and analyzes proteins to determine their role in disease	Commercial Services
York University York University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Verio Therapeutics, Inc. Verio Therapeutics, Inc. BiotechnologyHealth Technology Manufactures pharmaceutical products for activating endogenous stem cells	Health Technology
Privacy Analytics, Inc. Privacy Analytics, Inc. Packaged SoftwareTechnology Services Develops software for protecting the privacy of personal data used for analysis and research	Technology Services
Mercal Capital Corp. Mercal Capital Corp. Financial ConglomeratesFinance Operates as a capital pool company	Finance
Gleeson & Associates
Satellos Bioscience, Inc. /Old/ Satellos Bioscience, Inc. /Old/ BiotechnologyHealth Technology Engages in research and development of stem cell regeneration	Health Technology
Stem Cell Network Stem Cell Network Miscellaneous Commercial ServicesCommercial Services Engages in research & development and offers funding for stem cell regenerative medicine and provides training services	Commercial Services
Satellos Bioscience, Inc. Satellos Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company, which is focused on the identification, development and commercialization of drug candidates	Health Technology
Canadian Glycomics Network Canadian Glycomics Network BiotechnologyHealth Technology Develops new carbohydrate-based drugs, vaccines and diagnostics	Health Technology